Elizabeth Warren's New Target: 'Egregious' Conflicts of Interest in Trump's COVID-19 Response

日本 ニュース ニュース

Elizabeth Warren's New Target: 'Egregious' Conflicts of Interest in Trump's COVID-19 Response
日本 最新ニュース,日本 見出し
  • 📰 RollingStone
  • ⏱ Reading Time:
  • 68 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 31%
  • Publisher: 51%

“In a crisis with more than a hundred thousand Americans dead and tens of millions unemployed, White House decisions should be driven by science, rather than by personal profit,” Warren…

, he took his position on Operation Warp Speed as a contractor, which exempts him from strict federal conflict-of-interest requirements and from disclosing “his outside positions, stock holdings, and other potential conflicts.”that he refused to take the Operation Warp Speed role if he had to sell his stock, telling Trump administration officials that “I cannot take the job if I have to sell them.

Slaoui’s stake in GlaxoSmithKline alone is “an egregious conflict of interest given his role leading Operation Warp Speed,” Warren, Blumenthal, and Jayapal write. Slaoui also holds stock in several biotech and pharmaceutical companies that could benefit from the government’s accelerated vaccine-development efforts. And until recently, he had equity valued at more than $10 million in Moderna, a drug company that is conducting clinical trials for a COVID-19 vaccine.

Marc Short, chief of staff to Vice President Pence, owns between roughly $500,000 and $1.6 million worth of individual stocks in companies doing work related to the Trump administration’s pandemic response, according toOf those holdings, Short and his wife own stock worth between $101,000 and $340,000 in Johnson & Johnson, Pfizer, and Merck — three of the five companies selected by the Trump administration as finalists for a COVID-19 vaccine candidate.

“Because the Vice President is in a key decision-making role as leader of the Trump administration’s COVID-19 task force, it is unacceptable for his Chief of Staff to have a financial stake in companies that could profit based on actions taken in response to the COVID- 19 pandemic, whether in the development of vaccines or any other component of the response,” Warren, Blumenthal, and Jayapal write.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

RollingStone /  🏆 483. in US

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Warren Buffett's 'chronic underperformance' is frustrating investors and analysts | Markets InsiderWarren Buffett's 'chronic underperformance' is frustrating investors and analysts | Markets InsiderWarren Buffett is under fire for trailing the broader market and failing to strike deals and pile into stocks during the coronavirus sell-off. T...
続きを読む »

Timeline: The first 100 days of New York Gov. Andrew Cuomo's COVID-19 responseTimeline: The first 100 days of New York Gov. Andrew Cuomo's COVID-19 responseTIMELINE: The first 100 days of New York Gov. Andrew Cuomo's COVID-19 response.
続きを読む »

China's response to COVID-19 better than U.S.'s, global poll findsChina's response to COVID-19 better than U.S.'s, global poll findsFar more people around the world think China has responded well to the COVID-19 pandemic than those who think the United States has done a good job, a poll by the Alliance of Democracies Foundation showed on Monday.
続きを読む »

New Zealand military to oversee quarantine facilities after new COVID-19 caseNew Zealand military to oversee quarantine facilities after new COVID-19 caseNew Zealand on Wednesday said the defence force will now oversee the country's quarantine facilities and strengthen border requirements, after a slip up allowed two people with coronavirus to move around the country.
続きを読む »



Render Time: 2025-04-03 10:22:07